Less Ads, More Data, More Tools Register for FREE

Pin to quick picksStar Energy Regulatory News (STAR)

Share Price Information for Star Energy (STAR)

Share Price is delayed by 15 minutes
Get Live Data
19.00    0.40 (2.11%)
Bid:
18.00
Ask:
20.00
Spread: 2.00 (11.111%)
Market Cap: £37.37m
STAR Live PriceLast checked at - London Stock Exchange

Intraday Star Energy Share Chart

Trading Update

27 Feb 2017 07:00

RNS Number : 8863X
Starcom PLC
27 February 2017
 

 

 

27 February 2017

 

Starcom Plc

("Starcom" or the "Company")

 

 

Trading Update

 

Starcom (AIM: STAR), which specialises in the development of wireless solutions for the remote tracking, monitoring and protection of a variety of assets and people, is pleased to provide shareholders with an update in respect of the results for the year ended 31 December 2016, which are subject to final audit.

 

The Board expects turnover of not less than US$5.2m (FY 2015: US$5.1m).

 

The growth in revenues from the new Watchlock Pro has been held back due to delays in deliveries by Mul-T-Lok. An order of US$200,000, originally planned for delivery in 2016, will now be shipped and recognised in the 2017 financial year. The Company has now addressed this problem to ensure that it can meet the demand in a timely manner.

 

SAS revenues are expected to increase to US$1.7m during 2016, compared to US$1.6m in 2015. This growth was below plan due to one customer, who has so far connected only 1,500 Helios units out of over 10,000 ordered units by that customer. The customer continues to purchase further units and it is hoped more will be connected during this year.

 

The Board anticipates that the Company will report a loss before tax of approximately US$1.5m (FY 2015: loss of US$1.76m) after inventory write-downs of US$450,000, but before provisions referred to below. The preliminary results announcement is expected to be released by 31 March 2017.

 

The anticipated loss before tax is before any additional provisions which may be made in respect of receivables. In addition, the Board anticipates that it will shorten the amortisation period in respect of research and development costs to more properly reflect the speed of technology changes, resulting in a higher charge than would otherwise be the case.

 

Although the 2017 financial year is at a relatively early stage, the Board expects that the results for 2017 will show an improvement on those for 2016 based on the remedial actions mentioned above regarding Watchlock and the good level of new customer enquiries now being processed.

 

-ends-

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014.

 

For further information, please contact:

 

Starcom Plc

Michael Rosenberg, Chairman 07785 727 595

Avi Hartmann, CEO +972 5430 70103

+972 3619 9901

 

Northland Capital Partners Limited (Nominated Adviser and Broker) 020 3861 6625

Edward Hutton / David Hignell (Corporate Finance)

John Howes (Sales and Broking)

 

Peterhouse Corporate Finance (Joint Broker) 020 7469 0930

Lucy Williams / Charles Goodfellow / Eran Zucker

 

Leander PR (Financial PR) 020 7520 9267

Christian Taylor-Wilkinson 07795 168 157

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTQDLBLDLFFBBB
Date   Source Headline
28th May 20269:43 amRNSDirector/PDMR Shareholding
26th May 20267:00 amRNSExercise of Options and Total Voting Rights
21st May 20264:56 pmRNSHolding(s) in Company
21st May 20264:55 pmRNSHolding(s) in Company
21st May 20262:40 pmRNSHolding(s) in Company
21st May 202612:05 pmRNSBlock Listing Application
19th May 202610:46 amRNSHolding(s) in Company
18th May 202612:43 pmRNSResult of General Meeting and Total Voting Rights
7th May 20267:00 amRNSResult of Retail Offer
1st May 20267:01 amRNSProposed Retail Offer to raise up to £0.6 million
1st May 20267:00 amRNSResult of Fundraising and Notice of GM
30th Apr 20264:58 pmRNSLaunch of Placing, Subscription and Retail Offer
30th Apr 20262:53 pmRNSAdditional Listing Director/PDMR Shareholding
29th Apr 20267:00 amRNSHolding(s) in Company
29th Apr 20267:00 amRNSFinal Results
24th Apr 202611:34 amRNSSale of Croatian geothermal company
8th Apr 20262:35 pmRNSHolding(s) in Company
25th Feb 20267:00 amRNSTrading Update
29th Jan 20267:00 amRNSAdditional Listing Director/PDMR Shareholding
19th Dec 20259:57 amRNSBlock Listing Six Monthly Return
19th Dec 20259:57 amRNSBlock Listing Six Monthly Return
8th Dec 20252:30 pmRNSTotal Voting Rights
5th Dec 20257:00 amRNS-RInvestor Presentation via Investor Meet Company
17th Nov 202510:50 amRNSHolding(s) in Company
28th Oct 20257:00 amRNSAdditional Listing Director / PDMR Shareholding
22nd Sep 202511:18 amRNSHolding(s) in Company
19th Sep 20254:37 pmRNSHolding(s) in Company
19th Sep 20257:00 amRNS-RInvestor Presentation via Investor Meet Company
16th Sep 20257:00 amRNSHalf-year Report
5th Aug 20257:00 amRNSAdditional Listing Director/PDMR Shareholding
23rd Jun 20257:00 amRNS-RInvestor Presentation via Investor Meet Company
20th Jun 20257:00 amRNSBlock Listing Six Monthly Return
19th Jun 202512:29 pmRNSResult of AGM
19th Jun 20257:00 amRNS2025 Annual General Meeting Trading Update
10th Jun 20257:00 amRNSTotal Voting Rights
3rd Jun 20251:02 pmRNSForm 8.3 - Dowlais Group plc
3rd Jun 20251:00 pmRNSForm 8.3 - Qualcomm Incorporated
21st May 20251:16 pmRNSAnnual Report & Notice of Annual General Meeting
16th May 20257:00 amRNSGrant of Awards under Management Retention Plan
6th May 20257:00 amRNSPartnership with Veolia - Geothermal Projects
2nd May 20257:00 amRNSAdditional Listing Director/PDMR Shareholding
29th Apr 20257:00 amRNSFinal Results
22nd Apr 20256:00 pmRNSCompletion of Sale of Non-core Asset
8th Apr 20254:22 pmRNS-RReserves & Resources Update
31st Mar 20257:00 amRNS-RMoU with Bring Energy
6th Mar 20257:00 amRNSGrant of Awards
28th Feb 20252:11 pmRNS-RInvestor Presentation
24th Feb 20257:00 amRNSTrading Update
5th Feb 20257:00 amRNSTotal Voting Rights
30th Jan 20257:00 amRNSAdditional Listing Director/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.